Radiation therapy is considered a standard treatment option for the management of localized prostate cancer. Among the 20-30% of patients who recur, there is no consensus on the optimal salvage therapy. Salvage options available for isolated local recurrence include; temporary or permanent implantation of radioactive seeds into the prostate, complete removal of the prostate gland, use of low temperatures to treat the disease (cryotherapy), and high frequency ultrasound to treat the disease. There are risks of complications associated with all these treatments, and there is presently no consensus as to which treatment is the best. The aim of this pilot study is to look at the feasibility and toxicities of whole gland salvage treatment of the prostate using temporary implantation of radioactive seeds into the prostate.
Radiation therapy is considered a standard treatment option for the management of localized prostate cancer. Among the 20-30% of patients who recur, there is no consensus on the optimal salvage therapy. Salvage options available for isolated local recurrence include; temporary or permanent implantation of radioactive seeds into the prostate, complete removal of the prostate gland, use of low temperatures to treat the disease (cryotherapy), and high frequency ultrasound to treat the disease. There are risks of complications associated with all these treatments, and there is presently no consensus as to which treatment is the best. The aim of this pilot study is to look at the feasibility and toxicities of whole gland salvage treatment of the prostate using temporary implantation of radioactive seeds into the prostate. Reports of the efficacy and toxicities of whole gland salvage HDR brachytherapy for local recurrence after external beam radiation therapy are limited to single-institution studies with small sample sizes. Given that our institution has the highest volume of prostate brachytherapy cases in Ontario and that we receive a significant number of referrals from other cancer centres for brachytherapy, this study will aim to add to the literature and help guide salvage therapy practice within our institution.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Whole gland salvage
Odette Cancer Centre, Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Acute GI toxicities
Acute GI toxicities using NCI CTCAE v4.0
Time frame: 3 mths post brachytherapy
Acute GU toxicities
Acute GU toxicities utilizing NCI CTCAE v4.0
Time frame: 3 moths post brachytherapy
Acute GU symptoms
Acute GU symptoms American Urological Association Symptom Index Score (IPSS)
Time frame: 5 years
Late GU symptoms
Late GU symptoms American Urological Association Symptom Index Score (IPSS)
Time frame: 5 years
Late GI toxicities
Late GI toxicities using NCI CTCAE v.4.0
Time frame: 5 years
Late GU toxicities
Late GU Toxicities using NCI CTCAE v.4.0
Time frame: 5 years
Biochemical disease free survival
PSA
Time frame: 5 years
Quality of Life (QoL)
QoL measured using Expanded Prostate Cancer Index Composite (EPIC)
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.